ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Judge Sentences Former BMS Exec Bodner To Write Book Reflecting On His Experience

June 12, 2009

Chart of FY 1991 Budget For NCI By Mechanism

February 2, 1990

Jill ElkenberryTo Get ACCC Award

March 17, 1989

Congress Cuts $210 Million From NIH Budget For The Remainder of 2011

April 15, 2011

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting

December 11, 1987